Age | 64.6±11.4 | 63.6±10.3 | 64.0±12.2 | 62.8±12.6 | 64.0±11.5 | 0.98 |
Baseline NIHSS | 17.3±4.5 | 19.4±8.3 | 21.0±5.5 | 21.2±4.0 | 18.9±5.3 | 0.03 |
Male gender | 26 (65.0) | 4 (44.4) | 3 (33.3) | 11 (64.7) | 44 (58.7) | 0.26 |
Non-white | 7 (17.5) | 2 (22.2) | 1 (11.1) | 5 (29.4) | 15 (20.0) | 0.68 |
Atrial fibrillation | 11 (27.5) | 2 (22.2) | 2 (22.2) | 3 (17.7) | 18 (24.3) | 0.95 |
Baseline glucose | 120.1±42.6 | 116.1±19.4 | 169.0±104.2 | 125.2±38.8 | 126.6±52.5 | 0.68 |
Baseline systolic blood pressure | 143.8±22.6 | 150.1±10.4 | 143.7±20.9 | 147.4±21.0 | 145.4±20.7 | 0.83 |
Left hemisphere involved | 20 (50.0) | 6 (66.7) | 8 (88.9) | 11 (64.7) | 45 (60.0) | 0.17 |
Aphasia present | 19 (47.5) | 6 (66.7) | 8 (88.9) | 11 (64.7) | 44 (58.7) | 0.11 |
ICA occlusion | 7 (18.4) | 1 (11.1) | 2 (22.2) | 8 (47.1) | 18 (24.7) | 0.12 |
Onset to intravenous treatment (min) | 141.6±33.5 | 127.7±38.3 | 139.1±28.4 | 139.0±25.5 | 139.1±31.6 | 0.75 |
Received intra-arterial treatment | 25 (62.5) | 8 (88.9) | 8 (88.9) | 12 (70.6) | 53 (70.7) | 0.31 |
Onset to intra-arterial treatment (min) | 231.6±55.3 | 234.6±55.0 | 238.5±35.4 | 236.8±57.7 | 234.3±51.9 | 0.99 |
Duration of procedure (min) | 111.2±59.3 | 119.9±65.9 | 150.9±44.4 | 136.8±65.7 | 123.1±60.5 | 0.26 |